These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32639541)

  • 1. Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.
    Hall EL; Peravali R; Patel TS
    JAMA Dermatol; 2020 Sep; 156(9):1013. PubMed ID: 32639541
    [No Abstract]   [Full Text] [Related]  

  • 2. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
    Dam C; Bygum A
    Acta Derm Venereol; 2008; 88(1):87-9. PubMed ID: 18176768
    [No Abstract]   [Full Text] [Related]  

  • 3. Proton pump inhibitor-induced subcutaneous lupus erythematosus in a patient with systemic lupus erythematosus.
    Hung R; Sangle SR; Benton E; D'Cruz DP; McGibbon D
    Clin Exp Dermatol; 2015 Oct; 40(7):808-9. PubMed ID: 25809120
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lupus erythematosus and proto-pump inhibitors].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2014 Mar; 141(3):252-3. PubMed ID: 24635967
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A diffuse desquamative rash in an elderly male.
    Roman J; Nguyen KD; Dominguez AR
    Int J Dermatol; 2017 Aug; 56(8):e170-e172. PubMed ID: 28251610
    [No Abstract]   [Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.
    Ogawa-Momohara M; Muro Y; Goto K; Obuse C; Satoh M; Kono M; Akiyama M
    J Dermatol; 2020 Jun; 47(6):e217-e219. PubMed ID: 32173880
    [No Abstract]   [Full Text] [Related]  

  • 8. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.
    Durbin A; Callen JP; Schadt CR
    Dermatol Ther; 2022 Dec; 35(12):e15959. PubMed ID: 36284259
    [No Abstract]   [Full Text] [Related]  

  • 10. Proton Pump Inhibitor-Induced Subacute Cutaneous Lupus Erythematosus.
    Patel NB; Cuervo-Pardo L; Tan TL; Kundu RV; Chiarella SE
    J Allergy Clin Immunol Pract; 2020 Jan; 8(1):326-327. PubMed ID: 31427196
    [No Abstract]   [Full Text] [Related]  

  • 11. Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
    Bracke A; Nijsten T; Vandermaesen J; Meuleman L; Lambert J
    Acta Derm Venereol; 2005; 85(4):353-4. PubMed ID: 16191862
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
    Cookson H; Walsh S
    Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
    [No Abstract]   [Full Text] [Related]  

  • 13. Rowell's Syndrome Triggered by Omeprazole.
    Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation.
    Sontheimer RD; Henderson CL; Grau RH
    Arch Dermatol Res; 2009 Jan; 301(1):65-70. PubMed ID: 18797894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.
    Figueredo Zamora E; Callen JP; Schadt CR
    Lupus; 2021 Apr; 30(4):661-663. PubMed ID: 33349110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus.
    Hu FQ; Zhang YP; Yin J; Tang ZQ; Han YF; Shi ZR; Tan GZ; Wang L
    Lupus; 2021 Feb; 30(2):315-319. PubMed ID: 33086919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors Associated With Drug-Induced Lupus Erythematosus.
    Bataille P; Lebrun-Vignes B; Tubach F; Aroux-Pavard M; Philibert C; Chasset F; Barbaud A
    JAMA Dermatol; 2022 Oct; 158(10):1208-1210. PubMed ID: 35976639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous lupus erythematosus induced by golimumab therapy.
    Al Izzi M; Reda A
    Int J Rheum Dis; 2017 Dec; 20(12):2159-2161. PubMed ID: 27458030
    [No Abstract]   [Full Text] [Related]  

  • 20. Widespread Scaly Eruption in a Patient With Multiple Comorbidities.
    Jones EK; Mingioni N; Lee JB
    JAMA; 2015 Oct; 314(16):1740-1. PubMed ID: 26505598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.